Hepatic encephalopathy: effects of liver failure on brain function
- PMID: 24149188
- DOI: 10.1038/nrn3587
Hepatic encephalopathy: effects of liver failure on brain function
Abstract
Liver failure affects brain function, leading to neurological and psychiatric alterations; such alterations are referred to as hepatic encephalopathy (HE). Early diagnosis of minimal HE reveals an unexpectedly high incidence of mild cognitive impairment and psychomotor slowing in patients with liver cirrhosis - conditions that have serious health, social and economic consequences. The mechanisms responsible for the neurological alterations in HE are beginning to emerge. New therapeutic strategies acting on specific targets in the brain (phosphodiesterase 5, type A GABA receptors, cyclooxygenase and mitogen-activated protein kinase p38) have been shown to restore cognitive and motor function in animal models of chronic HE, and NMDA receptor antagonists have been shown to increase survival in acute liver failure. This article reviews the latest studies aimed at understanding how liver failure affects brain function and potential ways to ameliorate these effects.
Similar articles
-
Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy.J Steroid Biochem Mol Biol. 2016 Jun;160:88-93. doi: 10.1016/j.jsbmb.2015.08.020. Epub 2015 Aug 22. J Steroid Biochem Mol Biol. 2016. PMID: 26307490 Review.
-
Current theories on the pathogenesis of hepatic encephalopathy.Proc Soc Exp Biol Med. 1994 Sep;206(4):329-44. doi: 10.3181/00379727-206-43770. Proc Soc Exp Biol Med. 1994. PMID: 7915420 Review.
-
Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.World J Gastroenterol. 2006 Dec 28;12(48):7737-43. doi: 10.3748/wjg.v12.i48.7737. World J Gastroenterol. 2006. PMID: 17203513 Free PMC article. Review.
-
Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities.J Steroid Biochem Mol Biol. 2016 Jun;160:94-7. doi: 10.1016/j.jsbmb.2015.11.006. Epub 2015 Nov 14. J Steroid Biochem Mol Biol. 2016. PMID: 26589093 Review.
-
Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.J Neurol Sci. 1999 Nov 30;170(2):138-46. doi: 10.1016/s0022-510x(99)00169-0. J Neurol Sci. 1999. PMID: 10617392 Review.
Cited by
-
Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders.Neurobiol Dis. 2016 Jan;85:254-261. doi: 10.1016/j.nbd.2015.03.025. Epub 2015 Apr 3. Neurobiol Dis. 2016. PMID: 25843667 Free PMC article.
-
Identification of significant modules and hub genes involved in hepatic encephalopathy using WGCNA.Eur J Med Res. 2022 Nov 24;27(1):264. doi: 10.1186/s40001-022-00898-3. Eur J Med Res. 2022. PMID: 36424620 Free PMC article.
-
Impaired Tactile Temporal Discrimination in Patients With Hepatic Encephalopathy.Front Psychol. 2018 Oct 30;9:2059. doi: 10.3389/fpsyg.2018.02059. eCollection 2018. Front Psychol. 2018. PMID: 30425672 Free PMC article.
-
Hepatic Encephalopathy Mimicking Acute Dominant Middle Cerebral Artery Ischemic Stroke: A Case Report.Case Rep Neurol. 2019 Nov 20;11(3):304-311. doi: 10.1159/000504017. eCollection 2019 Sep-Dec. Case Rep Neurol. 2019. PMID: 31824285 Free PMC article.
-
Hyperammonemia Alters the Function of AMPA and NMDA Receptors in Hippocampus: Extracellular cGMP Reverses Some of These Alterations.Neurochem Res. 2022 Jul;47(7):2016-2031. doi: 10.1007/s11064-022-03588-y. Epub 2022 Apr 6. Neurochem Res. 2022. PMID: 35386048
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
